CS Fund 3 - Credit Suisse (CH) 130/30 Swiss Equity Fund UB CHF

Reference Data

ISIN CH0265300084
Valor Number 26530008
Bloomberg Global ID CCSEUBC SW
Fund Name CS Fund 3 - Credit Suisse (CH) 130/30 Swiss Equity Fund UB CHF
Fund Provider UBS AG, Zurich Basel, Switzerland
Phone: +41 61 288 75 01
E-Mail: sh-ubs-funds-feedback@ubs.com
Web: www.ubs.com/fonds
Fund Provider UBS AG, Zurich
Representative in Switzerland
Distributor(s) UBS AG
Basel
Phone: +41 61 288 20 20
Asset Class Equities
EFC Category Equity Switzerland
Distribution Policy Accumulation
Home Country Switzerland
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** A feature of the umbrella fund’s Subfund is that the fund management company may – in accordance with the respective investment policy focusing on particular countries or regions – increase the proportion of money invested to a maximum of 125% of a subfund’s net assets (leverage effect) by using derivatives and/or by taking out loans. The investment objective of this Subfund is primarily to achieve an appropriate return in the accounting currency by investing in the instruments listed below. Due account shall be taken of the principle of risk diversification, security of the capital invested and liquidity of the fund’s assets. This Subfund invests primarily in equities and equity-type securities (shares, dividendright certificates, shares in cooperatives, participation certificates, etc.) of companies domiciled in or carrying out the bulk of their business activities in Switzerland, and in other investments permitted under the fund contract.
Peculiarities

Fund Prices

Current Price * 22.05 CHF 02.12.2025
Previous Price * 21.97 CHF 01.12.2025
52 Week High * 22.33 CHF 07.03.2025
52 Week Low * 18.99 CHF 09.04.2025
NAV * 22.05 CHF 02.12.2025
Issue Price * 22.03 CHF 02.12.2025
Redemption Price * 22.03 CHF 02.12.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 257,573,187
Unit/Share Assets *** 40,687,591
Trading Information SIX

Performance

YTD Performance +11.59% 31.12.2024
02.12.2025
1 month +4.80% 03.11.2025
02.12.2025
3 months +5.60% 02.09.2025
02.12.2025
6 months +2.94% 02.06.2025
02.12.2025
1 year +10.03% 02.12.2024
02.12.2025
2 years +14.19% 04.12.2023
02.12.2025
3 years +16.61% 02.12.2022
02.12.2025
5 years +28.20% 02.12.2020
02.12.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Roche Holding AG 15.20%
Nestle SA 14.52%
Novartis AG Registered Shares 11.37%
UBS Group AG Registered Shares 7.53%
Zurich Insurance Group AG 6.24%
ABB Ltd 5.55%
Compagnie Financiere Richemont SA Class A 4.33%
Lonza Group Ltd 4.20%
Swiss Re AG 4.10%
Chocoladefabriken Lindt & Spruengli AG Ordinary Shares - Non Voting 3.88%
Last data update 31.10.2025

Cost / Risk

TER 0.77%
TER date 31.05.2025
Performance Fee *** 15.00%
PTR
Max. Management Fee *** 1.00%
Ongoing Charges *** 0.77%
SRRI ***
SRRI date *** 31.10.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)